Tag: Edesa Biotech

Business

Edesa Biotech Inc (NASDAQ: EDSA) proclaims Hopeful Assessment of COVID-19 Review

Edesa Biotech Inc (NASDAQ: EDSA), a pharmaceutical corporation, today indicated that an autonomous Data and Safety Monitoring Board (DSMB) had finalized a preponderant assessment of the business’s COVID-19 medication applicant. The appraisal founded on blinded proportional statistics has suggested that the company’s global revision continue as intended. The safety monitoring […]